For AI agents: read the machine-readable documentation index at /llms.txt or the single-file full reference at /llms-full.txt.
Form a Business

Eligibility requirements for treatment with investigational drug, biological product, or device

KRS 217.5403
in effect
Sign in to generate a plain English summaryAsk Belisarius Agent
217.5403. Eligibility requirements for treatment with investigational drug, biological product, or device A patient shall be eligible for treatment with an investigational drug, biological product, or device if the patient has: (1) A terminal illness that is attested to by the patient's treating health care provider; (2) Considered all other treatment options currently approved by the United States Food and Drug Administration; (3) Received a recommendation from the patient's treating health care provider for an investigational drug, biological product, or device; (4) Given written informed consent for the use of the investigational drug, biological product, or device; and (5) Documentation from the treating health care provider that the patient meets the requirements of this section. Effective: June 29, 2017 History: Created 2017 Ky. Acts ch. 65, sec. 3, effective June 29, 2017. Formerly codified as KRS 217.5405.
Source: Kentucky Legislative Research Commission (legislature.ky.gov)URL: https://apps.legislature.ky.gov/law/statutes/statute.aspx?id=46073Fetched: 10/20/2026

Starting a business in Kentucky? Kentucky LLC guide: costs and requirements